Cancer Treatment News and Research

RSS

Two novel therapies for multiple myeloma

Two novel biologics are currently being investigated for their potential benefit to multiple myeloma patients in separate ongoing clinical trials at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

14 Mar 2007

Inhaled Celecoxib shows new promise for lung cancer treatment

In recent years, Cycloxygenase (COX)-2 has emerged as a therapeutic target for the prevention and treatment of various types of cancers.

6 Mar 2007

Mayo Clinic tests engineered measles virus against multiple myeloma

Mayo Clinic Cancer Center has opened a new Phase I clinical trial testing an engineered measles virus against multiple myeloma, a cancer of the bone marrow that currently has no cure. This is the third of a series of molecular medicine studies in patients testing the potential of measles to kill cancer.

5 Mar 2007

Effect of depression in mothers with breast cancer on their children's concerns

A woman's breast cancer diagnosis can wreak as much havoc on her emotions as it does on her physical health. Mothers who experience bouts of depression during their battles with breast cancer may find that the effects reach beyond their own psyches to those of their children.

5 Mar 2007

Drug industry influences breast cancer research

Breast cancer treatment trials supported by the pharmaceutical industry are more likely to report positive results than non-sponsored studies, according to a study to be published in the April 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

27 Feb 2007

Association between pharmaceutical involvement and outcomes in breast cancer clinical trials

26 Feb 2007

Clarient receives patent for "automated detection of objects in a biological sample"

Clarient, Inc. has announced that it has been granted a new U.S. patent related to the detection and quantification of rare tumor cells in blood and bone marrow.

21 Feb 2007

Researchers discover markers that identify breast cancer subtypes resistant to Herceptin

Using gene chips to profile tumors before treatment, researchers at Harvard and Yale Universities found markers that identified breast cancer subtypes resistant to Herceptin, the primary treatment for HER2-positive breast cancer. They say this advance could help further refine therapy for the 25 to 30 percent of breast cancer patients with this class of tumor.

20 Feb 2007

How T cells attack tumors

Our immune system struggles to eliminate tumors effectively. By unraveling its strategies, we can enhance its effects on tumor cells and so improve the clinical prospects of cancer immunotherapy.

20 Feb 2007

Health professionals would prioritize spending on the young over the old

In prioritizing health care spending, health professionals rank childhood immunization highest and cancer treatment for smokers lowest, according to a new international survey published in PLoS Medicine.

20 Feb 2007

Cell pathway identified which plays critical role in colon cancer

For the one in 18 men and women who will be diagnosed with cancer of the colon and rectum during their lifetime and over 150,000 people diagnosed on a yearly basis, today's genetic research news offers some optimism.

20 Feb 2007

Group exercise helps breast cancer sufferers

Group exercise sessions can help to improve the physical and psychological wellbeing of people diagnosed with breast cancer, a new British Medical Journal study reveals.

18 Feb 2007

New breast cancer drug Exemestane shows great potential to save lives

In what will be welcome news to millions of women suffering from breast cancer, trials of a new drug have found it lowers oestrogen levels in women with hormone-sensitive breast cancer and has the potential to save more than 1,000 lives a year in the UK alone.

13 Feb 2007

Changes in breast cancer management

Aggressive research currently underway brings hope of dramatic advances in breast cancer management, according to a new review.

12 Feb 2007

New method of screening tumors for cancer-related gene abnormalities

A study led by researchers at Dana-Farber Cancer Institute and Broad Institute of the Massachusetts Institute of Technology and Harvard University provides the first demonstration of a practical method of screening tumors for cancer-related gene abnormalities that might be treated with "targeted" drugs.

11 Feb 2007

Machine learning speeds up Intensity Modulated Radiation Therapy

A new computer-based technique could eliminate hours of manual adjustment associated with a popular cancer treatment.

7 Feb 2007

Potential new cancer fighting drug found by mistake

Researchers in the United States appear to have almost inadvertently stumbled across what could be a new cancer treatment.

5 Feb 2007

Access Pharmaceuticals issued U.S. patent

This patent, entitled "O,O'-Amidomalonato and N,O-Amidomalonato Platinum Complexes" is one of a series of patents and patent applications owned by Access which provides intellectual property protection to ProLindac and related tumor-targeted platinum compounds.

30 Jan 2007

Young single men are more likely to bank sperm before testicular cancer treatment

A quarter of men with testicular cancer banked their sperm before treatment, but only six per cent of those actually used the sperm to father a child, according to a study published in the January issue of the UK-based urology journal BJU International.

8 Jan 2007

First year of cancer treatment costs patients $2.3 billion in lost time

The time that cancer patients nationwide spend when they travel to, wait for and receive inpatient and outpatient treatment costs an estimated $2.3 billion in the first year after diagnosis, according to a study published on Wednesday in the Journal of the National Cancer Institute, the AP/South Florida Sun-Sentinel reports.

7 Jan 2007